These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
273 related items for PubMed ID: 1596044
1. Treatment of human brucellosis with doxycycline plus rifampin or doxycycline plus streptomycin. A randomized, double-blind study. Ariza J, Gudiol F, Pallares R, Viladrich PF, Rufi G, Corredoira J, Miravitlles MR. Ann Intern Med; 1992 Jul 01; 117(1):25-30. PubMed ID: 1596044 [Abstract] [Full Text] [Related]
2. Doxycycline-rifampin versus doxycycline-streptomycin in treatment of human brucellosis due to Brucella melitensis. The GECMEI Group. Grupo de Estudio de Castilla-la Mancha de Enfermedades Infecciosas. Solera J, Rodríguez-Zapata M, Geijo P, Largo J, Paulino J, Sáez L, Martínez-Alfaro E, Sánchez L, Sepulveda MA, Ruiz-Ribó MD. Antimicrob Agents Chemother; 1995 Sep 01; 39(9):2061-7. PubMed ID: 8540716 [Abstract] [Full Text] [Related]
3. Comparison of five antimicrobial regimens for the treatment of brucellar spondylitis: a prospective, randomized study. Bayindir Y, Sonmez E, Aladag A, Buyukberber N. J Chemother; 2003 Oct 01; 15(5):466-71. PubMed ID: 14598939 [Abstract] [Full Text] [Related]
4. Comparative trial of rifampin-doxycycline versus tetracycline-streptomycin in the therapy of human brucellosis. Ariza J, Gudiol F, Pallarés R, Rufí G, Fernández-Viladrich P. Antimicrob Agents Chemother; 1985 Oct 01; 28(4):548-51. PubMed ID: 4073878 [Abstract] [Full Text] [Related]
5. [A comparative therapeutic and multicenter trial of rifampicin and doxycycline versus streptomycin and doxycycline in human brucellosis]. Solera J, Medrano F, Rodríguez M, Geijo P, Paulino J. Med Clin (Barc); 1991 May 04; 96(17):649-53. PubMed ID: 1905372 [Abstract] [Full Text] [Related]
6. Efficacy of gentamicin plus doxycycline versus streptomycin plus doxycycline in the treatment of brucellosis in humans. Hasanjani Roushan MR, Mohraz M, Hajiahmadi M, Ramzani A, Valayati AA. Clin Infect Dis; 2006 Apr 15; 42(8):1075-80. PubMed ID: 16575723 [Abstract] [Full Text] [Related]
7. Comparison between doxycycline-rifampin-amikacin and doxycycline-rifampin regimens in the treatment of brucellosis. Ranjbar M, Keramat F, Mamani M, Kia AR, Khalilian FO, Hashemi SH, Nojomi M. Int J Infect Dis; 2007 Mar 15; 11(2):152-6. PubMed ID: 16798042 [Abstract] [Full Text] [Related]
8. Comparison of doxycycline-streptomycin, doxycycline-rifampin, and ofloxacin-rifampin in the treatment of brucellosis: a randomized clinical trial. Hashemi SH, Gachkar L, Keramat F, Mamani M, Hajilooi M, Janbakhsh A, Majzoobi MM, Mahjub H. Int J Infect Dis; 2012 Apr 15; 16(4):e247-51. PubMed ID: 22296864 [Abstract] [Full Text] [Related]
9. Comparison of three different combination therapies in the treatment of human brucellosis. Ersoy Y, Sonmez E, Tevfik MR, But AD. Trop Doct; 2005 Oct 15; 35(4):210-2. PubMed ID: 16354469 [Abstract] [Full Text] [Related]
11. Comparative trial of doxycycline plus streptomycin versus doxycycline plus rifampin for the therapy of human brucellosis. Colmenero Castillo JD, Hernandez Marquez S, Reguera Iglesias JM, Cabrera Franquelo F, Rius Diaz F, Alonso A. Chemotherapy; 1989 Oct 15; 35(2):146-52. PubMed ID: 2667903 [Abstract] [Full Text] [Related]
12. Administration of a triple versus a standard double antimicrobial regimen for human brucellosis more efficiently eliminates bacterial DNA load. Vrioni G, Bourdakis A, Pappas G, Pitiriga V, Mavrouli M, Pournaras S, Tsakris A. Antimicrob Agents Chemother; 2014 Dec 15; 58(12):7541-4. PubMed ID: 25246401 [Abstract] [Full Text] [Related]
13. Outcomes of treatment in 50 cases with spinal brucellosis in Babol, Northern Iran. Smailnejad Gangi SM, Hasanjani Roushan MR, Janmohammadi N, Mehraeen R, Soleimani Amiri MJ, Khalilian E. J Infect Dev Ctries; 2012 Sep 17; 6(9):654-9. PubMed ID: 23000864 [Abstract] [Full Text] [Related]
14. A comparative trial of three therapeutic regimens: ciprofloxacin-rifampin, ciprofloxacin-doxycycline and doxycycline-rifampin in the treatment of brucellosis. Keramat F, Ranjbar M, Mamani M, Hashemi SH, Zeraati F. Trop Doct; 2009 Oct 17; 39(4):207-10. PubMed ID: 19762571 [Abstract] [Full Text] [Related]
15. Multicenter prospective study of treatment of Brucella melitensis brucellosis with doxycycline for 6 weeks plus streptomycin for 2 weeks. Cisneros JM, Viciana P, Colmenero J, Pachón J, Martinez C, Alarcón A. Antimicrob Agents Chemother; 1990 May 17; 34(5):881-3. PubMed ID: 2193624 [Abstract] [Full Text] [Related]
16. Ofloxacin plus rifampicin versus doxycycline plus rifampicin in the treatment of brucellosis: a randomized clinical trial [ISRCTN11871179]. Karabay O, Sencan I, Kayas D, Sahin I. BMC Infect Dis; 2004 Jun 23; 4():18. PubMed ID: 15214959 [Abstract] [Full Text] [Related]
18. Possible implications of doxycycline-rifampin interaction for treatment of brucellosis. Colmenero JD, Fernández-Gallardo LC, Agúndez JA, Sedeño J, Benítez J, Valverde E. Antimicrob Agents Chemother; 1994 Dec 23; 38(12):2798-802. PubMed ID: 7695265 [Abstract] [Full Text] [Related]
19. Therapy of experimental murine brucellosis with streptomycin alone and in combination with ciprofloxacin, doxycycline, and rifampin. Lang R, Shasha B, Rubinstein E. Antimicrob Agents Chemother; 1993 Nov 23; 37(11):2333-6. PubMed ID: 8285615 [Abstract] [Full Text] [Related]
20. Epidemiological, clinical, biochemical, and treatment characteristics of brucellosis cases in Turkey. Arslan M, Ertunç B, Düz ME, Menekşe E, Avci BY, Avci E, Yilmaz G. J Infect Dev Ctries; 2024 Jul 29; 18(7):1066-1073. PubMed ID: 39078792 [Abstract] [Full Text] [Related] Page: [Next] [New Search]